Esperion Therapeutics shares owned by Citigroup
Quarter-by-quarter ownership of Esperion Therapeutics (ESPR) shares owned by Citigroup
from 13F filings
Historical chart of Citigroup investment in Esperion Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Esperion Therapeutics held by Citigroup consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Esperion Therapeutics by Citigroup
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2026-03-31 | $841k | 307k | 2.74 |
| 2025-03-31 | $269k | 187k | 1.44 |
| 2024-12-31 | $704k | 320k | 2.20 |
| 2024-09-30 | $485k | 294k | 1.65 |
| 2024-06-30 | $393k | 178k | 2.21 |
| 2024-03-31 | $1.5M | 557k | 2.68 |
| 2023-12-31 | $1.1M | 381k | 3.00 |
| 2023-09-30 | $15k | 15k | 0.98 |
| 2023-03-31 | $64k | 40k | 1.59 |
| 2022-12-31 | $98k | 16k | 6.23 |
| 2022-09-30 | $87k | 13k | 6.67 |
| 2021-12-31 | $73k | 15k | 4.99 |
| 2021-03-31 | $4.6M | 165k | 28.05 |
| 2020-12-31 | $1.7M | 64k | 26.12 |
| 2020-09-30 | $2.5M | 67k | 37.19 |
| 2020-06-30 | $4.3M | 84k | 51.37 |
| 2020-03-31 | $2.1M | 66k | 31.55 |
| 2019-12-31 | $5.0M | 85k | 59.71 |
| 2019-09-30 | $5.5M | 151k | 36.66 |
| 2019-06-30 | $9.6M | 206k | 46.51 |
| 2019-03-31 | $2.5M | 62k | 40.10 |
| 2018-12-31 | $13M | 288k | 46.03 |
| 2018-09-30 | $6.6M | 148k | 44.38 |
| 2018-06-30 | $3.0M | 77k | 39.19 |
| 2018-03-31 | $2.9M | 40k | 72.41 |
| 2017-12-31 | $5.3M | 80k | 65.84 |
| 2017-09-30 | $2.5M | 50k | 50.13 |
| 2017-06-30 | $3.7M | 80k | 46.29 |
| 2017-03-31 | $1.6M | 44k | 35.30 |
| 2016-12-31 | $343k | 27k | 12.54 |
| 2016-09-30 | $388k | 28k | 14.00 |
| 2016-06-30 | $310k | 31k | 10.00 |
| 2015-12-31 | $919k | 46k | 20.00 |
| 2015-09-30 | $762k | 32k | 23.55 |
| 2015-06-30 | $1.8M | 22k | 80.81 |
| 2014-09-30 | $415k | 19k | 21.43 |
| 2014-03-31 | $284k | 19k | 15.12 |
| 2013-12-31 | $262k | 19k | 13.57 |
| 2013-09-30 | $200k | 11k | 18.86 |